The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Characterization of isolated, uncomplicated neutropenia–related to the CDK4/6 inhibitor palbociclib.
Angela DeMichele
Consultant or Advisory Role - Pfizer (U)
Research Funding - Pfizer
Mark Andrew Dickson
Research Funding - Pfizer
Amy Sanders Clark
No relevant relationships to disclose
Christopher Colameco
No relevant relationships to disclose
Maryann Gallagher
No relevant relationships to disclose
Kristi Gramlich
No relevant relationships to disclose
Kelly Zafman
No relevant relationships to disclose
David Lewis
No relevant relationships to disclose
Melissa Langer
No relevant relationships to disclose
David J. Vaughn
No relevant relationships to disclose
Gary K. Schwartz
No relevant relationships to disclose
Peter J. O'Dwyer
Research Funding - Pfizer